false
0001994624
0001994624
2025-10-08
2025-10-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): October 8, 2025
ScanTech AI Systems Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-42463 |
|
93-3502562 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
|
1735 Enterprise Drive
Buford, Georgia |
|
30518 |
| (Address of principal executive offices) |
|
(Zip Code) |
+1 (470) 655-0886
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of
the Act:
| Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
STAI |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 1.01 |
Entry into a Material Definitive Agreement. |
On October 8, 2025, ScanTech AI Systems Inc. (the “Company”)
entered into a Purchase Agreement, dated as of October 8, 2025 (the “ELOC Purchase Agreement”), with ARC Group International
Ltd. (the “Investor”), for an equity line of credit. Under the ELOC Purchase Agreement, the Company has the right, but not
the obligation, to direct the Investor to purchase up to $50 million (the “Commitment Amount”) in shares of the Company’s
common stock, par value $0.0001 per share, subject to the terms and conditions contained in the ELOC Purchase Agreement (such shares to
be purchased, the “Purchase Shares”). In addition, pursuant to the ELOC Purchase Agreement, the Investor agreed to purchase
1,403,863 shares (the “Subscription Shares”) of the Company’s common stock from the Company for a purchase price equal
to $500,000 in the aggregate at a purchase price per share of $0.35616 per share.
Pursuant to the ELOC Purchase Agreement, the Company is required to
file a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) registering the resale of the Company’s
common stock issued under the ELOC Purchase Agreement (the “Registrable Securities”) within 60 calendar days of the date of
the ELOC Purchase Agreement, and the Company must use its best efforts to have such registration statement be declared effective by the
SEC as soon as possible following the filing thereof but in no event later than 90 calendar days following the initial filing of the initial
registration statement. The Company cannot deliver an Advance Notice until there is an effective registration statement for the resale
of the Registrable Securities.
During the term of the ELOC Purchase Agreement, the Company may direct
the Investor to purchase a certain portion of the Commitment Amount (an “Advance”) by delivering a notice (“Advance
Notice”) to the Investor, subject to the terms and conditions in the ELOC Purchase Agreement. The Company shall, in its sole discretion,
select the amount of the Advance requested by the Company in each Advance Notice. However, each requested Advance may not exceed the lesser
of (i) 75% of the average of the Daily Value Traded (as defined in the ELOC Purchase Agreement) of the Company’s common stock over
the 10 trading days immediately preceding an Advance Notice, or (ii) $5,000,000, subject to modification by the parties’ mutual
prior written consent.
If no Advance is ongoing pursuant to a valid Advance Notice at the
time the Company delivers an Advance Notice to the Investor, then the purchase price to be paid by the Investor for the Purchase Shares
will be 96% of the average daily VWAP of the Company’s common stock during the three trading days commencing on the date of the
Investor’s receipt of the Purchase Shares relating to such Advance Notice. If the Company delivers an Advance Notice to the Investor
on or prior to the settlement date of an ongoing Advance, then the purchase price to be paid by the Investor for the Purchase Shares will
be 100% of the average intraday sale price of the Company’s common stock on the same Trading Day the Advance Notice is received
after 8:30 a.m. Eastern Time.
Each Advance is subject to the following limitations: (i) the Company
may not conduct a sale under the ELOC Purchase Agreement to the extent that it would cause the aggregate number of shares of common stock
beneficially owned (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
by the Investor and its affiliates as a result of previous issuances and sales of shares to the Investor under the ELOC Purchase Agreement
to exceed 4.99% of the then issued and outstanding shares of the Company’s common stock (the “Ownership Limitation”);
and (ii) no Advance may be in excess of the Registrable Securities covered by an effective registration statement then in effect.
Notwithstanding anything to the contrary in the ELOC Purchase
Agreement, the Company may not effect any sales under the ELOC Purchase Agreement and the Investor will not have the obligation to
purchase common stock thereunder to the extent (but only to the extent) that after giving effect to such purchase and sale the
aggregate number of the Company’s common stock issued under the ELOC Purchase Agreement (including all of the Registrable
Securities) would exceed 19.99% of the issued and outstanding shares of the Company’s common stock as of the date of the ELOC
Purchase Agreement (the “Exchange Cap”) unless the Company obtains the requisite stockholder approval for issuances in
excess of the Exchange Cap.
In consideration for the Investor’s execution and delivery of
the ELOC Purchase Agreement, the Company agreed to issue 3,869,969 shares of the Company’s common stock to the Investor (the “Commitment
Fee Shares”), having an aggregate value of $1,750,000. The Commitment Fee Shares were deemed fully earned on the date of the ELOC
Purchase Agreement. Pursuant to the terms of the ELOC Purchase Agreement, the Company agreed to issue to the Investor in satisfaction
of its obligations for the Commitment Fee Shares and Subscription Shares, 3,365,934 shares of common stock and 1,907,898 pre-funded warrants
to purchase shares of common stock (the “Pre-Funded Warrants”). Each Pre-Funded Warrant has a nominal exercise price of $0.0001
per share, was pre-funded at issuance, and is exercisable at any time after issuance subject to a 4.99%/9.99% beneficial ownership limitation.
The Investor generally may, upon delivery of a written notice to the Company, increase or decrease such beneficial ownership limitation
to any other percentage not in excess of 9.99% as specified in such notice effective on the 61st day after such notice is delivered to
the Company.
The Company agreed to be responsible for all of Investor’s legal
fees in connection with the ELOC Purchase Agreement, but not exceeding $30,000 in the aggregate, and Investor acknowledged and agreed
that the Company had already paid $10,000 of such aggregate amount.
The ELOC Purchase Agreement terminates automatically on the earliest
of (i) the day that is the 36-month anniversary of the date of the ELOC Purchase Agreement, or (ii) the date on which the Investor shall
have made payment for Advances equal to the Commitment Amount. The Company may terminate the ELOC Purchase Agreement upon five trading
days’ prior written notice to the Investor, provided that there are no outstanding Advance Notices and the Company has paid all
amounts owed to the Investor pursuant to the ELOC Purchase Agreement, including the Commitment Fee Shares and the Subscription Shares.
The parties may also terminate the ELOC Purchase Agreement at any time by mutual written consent.
The ELOC Purchase Agreement contains customary representations, warranties,
conditions, and indemnification obligations of the parties. The representations, warranties, and covenants contained in such the ELOC
Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties
to such agreement, and may be subject to limitations agreed upon by the contracting parties.
The Company intends to use the net proceeds from sale of the Subscription
Shares and any subsequent sales under the ELOC Purchase Agreement for working capital, advancement of its AI-driven security technologies,
and general corporate purposes .
The foregoing description of the ELOC Purchase Agreement and Pre-Funded
Warrants does not purport to be complete and is qualified in its entirety by reference to the full texts of the ELOC Purchase Agreement
and form of Pre-Funded Warrants, copies of which are filed as Exhibits 10.1 and 4.1, respectively, to this Current Report on Form 8-K
and are incorporated herein by reference.
| Item 3.02. |
Unregistered Sales of Equity Securities. |
The information set forth under Item 1.01 of this Current Report on
Form 8-K is incorporated herein by reference.
The securities issued or that may be issued by the Company to the Investor
under the ELOC Purchase Agreement are being offered and sold by the Company to the Investor in a transaction that is exempt from the registration
requirements of the Securities Act of 1933, as amended (the “Securities Act”), in reliance on Section 4(a)(2) of the Securities
Act and/or Rule 506(b) of Regulation D thereunder. In the ELOC Purchase Agreement, the Investor represented to the Company, among other
things, that it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act).
Accordingly, the offer and sale by the Company of the securities issued or that may be issued and sold to the Investor under the ELOC
Purchase Agreement have not been registered under the Securities Act or any applicable state securities or “blue sky” laws
and, therefore, such securities may not be offered or sold in the United States absent registration or an exemption from registration
under the Securities Act and any applicable state securities or “blue sky” laws.
This Current Report on Form 8-K shall not constitute an offer to sell
or a solicitation of an offer to buy any securities of the Company, nor shall there be any sale of any securities of the Company in any
state or other jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or other jurisdiction.
| Item 7.01. |
Regulation FD Disclosure. |
On October 9, 2025, the Company issued a press release announcing
its entry into the ELOC Purchase Agreement and the initial investment described therein. A copy of the press release is furnished as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 7.01, including
Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange
Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the
Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
| Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. |
|
Description |
| 4.1 |
|
Form of Pre-Funded Warrant. |
| 10.1 |
|
Purchase Agreement, dated as of October 8, 2025, between the Company and ARC Group International Ltd. |
| 99.1 |
|
Press Release, dated October 10, 2025 |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: October 10, 2025 |
SCANTECH AI SYSTEMS INC. |
| |
|
| |
By: |
/s/ Dolan Falconer |
| |
Name: |
Dolan Falconer |
| |
Title: |
Chief Executive Officer |
